BeOne Medicines (ONC) Return on Sales (2015 - 2026)

BeOne Medicines (ONC) has 12 years of Return on Sales data on file, last reported at 0.0% in Q1 2026.

• Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
• Return on Sales grew to 0.0% in Q1 2026 per ONC's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Sales topped out at 0.0% in Q3 2023 and bottomed at 0.02% in Q2 2022.
• The 5-year median for Return on Sales is 0.0% (2024), against an average of 0.0%.
• Peak annual rise in Return on Sales reached 2 bps in 2022, while the deepest fall reached 2 bps in 2022.
• Tracing ONC's Return on Sales over 5 years: stood at 0.01% in 2022, then jumped by 51 bps to 0.01% in 2023, then jumped by 77 bps to 0.0% in 2024, then soared by 133 bps to 0.0% in 2025, then jumped by 238 bps to 0.0% in 2026.
• Per Business Quant, the three latest ONC Return on Sales figures stand at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025).

Peer Comparison